fruzaqla - fruquintinib capsule
(Fruquintinib)Takeda Pharmaceuticals America, Inc.
Usage: Fruzaqla treats metastatic colorectal cancer (mCRC) in adults previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy.